These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 30158766)
1. Immunohistochemical study of salivary gland tumors in a tertiary institution in South-South Region of Nigeria. Omitola OG; Iyogun CA J Oral Maxillofac Pathol; 2018; 22(2):163-167. PubMed ID: 30158766 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical pattern of pleomorphic adenoma, polymorphous low grade adenocarcinoma and adenoid cystic carcinoma in minor salivary glands. Zaib N; Mushtaq S; Mamoon N; Akhter N; Ayaz B J Dent (Tehran); 2014 Jan; 11(1):38-46. PubMed ID: 24910675 [TBL] [Abstract][Full Text] [Related]
3. Expression of α-smooth muscle actin in benign and malignant salivary gland tumors: An immunohistochemical study. Ravi M; Boaz K; Natarajan S; Lewis A; Prasad M; Yellapurkar S Indian J Pathol Microbiol; 2018; 61(4):479-484. PubMed ID: 30303133 [TBL] [Abstract][Full Text] [Related]
4. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Edwards PC; Bhuiya T; Kelsch RD Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875 [TBL] [Abstract][Full Text] [Related]
5. Polymorphous low grade adenocarcinoma has a consistent p63+/p40- immunophenotype that helps distinguish it from adenoid cystic carcinoma and cellular pleomorphic adenoma. Rooper L; Sharma R; Bishop JA Head Neck Pathol; 2015 Mar; 9(1):79-84. PubMed ID: 24969705 [TBL] [Abstract][Full Text] [Related]
6. Comparison of p63/p40 Expression With Myoepithelial Markers in Minor Salivary Gland Tumors. Teixeira LN; Janner ÉC; Teixeira T; Passador-Santos F; Martinez EF; Demasi APD; de Araújo NS; de Araújo VC Int J Surg Pathol; 2019 Jun; 27(4):360-371. PubMed ID: 30482064 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of c-kit protein (CD117) expression in common salivary gland neoplasms. Salehinejad J; Mohtasham N; Bagherpour A; Abbaszadeh-Bidokhty H; Ghazi A J Oral Maxillofac Pathol; 2014 May; 18(2):177-82. PubMed ID: 25328295 [TBL] [Abstract][Full Text] [Related]
8. Comparative Analysis of P63, Maspin and Matrix Metalloproteinase 2 Expression in Mucoepidermoid Carcinoma and Adenoid Cystic Carcinoma of Salivary Glands. Taghavi N; Yazdani F; Akbarzadeh Baghban A; Sargolzaei S; Kardouni Khoozestani P J Dent (Shiraz); 2020 Jun; 21(2):95-101. PubMed ID: 32582823 [TBL] [Abstract][Full Text] [Related]
9. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Prasad AR; Savera AT; Gown AM; Zarbo RJ Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827 [TBL] [Abstract][Full Text] [Related]
10. Salivary gland-like tumors of the breast express basal-type immunohistochemical markers. Reyes C; Jorda M; Gomez-Fernández C Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):283-6. PubMed ID: 22935826 [TBL] [Abstract][Full Text] [Related]
11. Adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of minor salivary glands: a comparative immunohistochemical study using the epithelial membrane and carcinoembryonic antibodies. Epivatianos A; Iordanides S; Zaraboukas T; Antoniades D Oral Dis; 2005 May; 11(3):175-80. PubMed ID: 15888109 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Diagnostic Reliability of p63 and Smooth Muscle Actin in Salivary Gland Neoplasms. Aswani E; Sherlin HJ; Jayaraj G; Don KR; Santhanam A Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2520-2526. PubMed ID: 36452668 [TBL] [Abstract][Full Text] [Related]
13. Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma. Beltran D; Faquin WC; Gallagher G; August M J Oral Maxillofac Surg; 2006 Mar; 64(3):415-23. PubMed ID: 16487803 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Utility of Immunohistochemical Expressions of IMP3 Versus DOG1 and p63 in Salivary Gland Tumors. Ibrahim TR; Ahmed MM; Hegazy AA Turk Patoloji Derg; 2020; 36(3):227-236. PubMed ID: 32692399 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of C-kit protein (CD117) expression in differentiating adenoid cystic carcinoma and polymorphous low grade Adenocarcinoma. Tariq H; Anjum S; Din HU; Akhtar F Pak J Med Sci; 2017; 33(6):1376-1380. PubMed ID: 29492062 [TBL] [Abstract][Full Text] [Related]
16. Assessment of proliferative activity using the MIB1 antibody help to distinguish polymorphous low grade adenocarcinoma from adenoid cystic carcinoma of salivary glands. Skálová A; Simpson RH; Lehtonen H; Leivo I Pathol Res Pract; 1997; 193(10):695-703. PubMed ID: 9505262 [TBL] [Abstract][Full Text] [Related]
17. Hyaluronan and CD44 expression in minor salivary gland tumors. Xing R; Regezi JA; Stern M; Shuster S; Stern R Oral Dis; 1998 Dec; 4(4):241-7. PubMed ID: 10200702 [TBL] [Abstract][Full Text] [Related]
18. Dendritic interstitial and myofibroblastic cells at the border of salivary gland tumors. Soma L; LiVolsi VA; Baloch ZW Arch Pathol Lab Med; 2001 Feb; 125(2):232-6. PubMed ID: 11175641 [TBL] [Abstract][Full Text] [Related]
19. Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB-2, FAS and Ki-67. Ito FA; Ito K; Coletta RD; Graner E; de Almeida OP; Lopes MA Anal Quant Cytol Histol; 2009 Oct; 31(5):280-7. PubMed ID: 20701095 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors. Rotellini M; Palomba A; Baroni G; Franchi A Appl Immunohistochem Mol Morphol; 2014; 22(5):390-4. PubMed ID: 23958548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]